Risk of cancer in young and older patients with congenital heart disease and the excess risk of cancer by syndromes, organ transplantation and cardiac surgery: Swedish health registry study (1930-2017)
- PMID: 35663362
- PMCID: PMC9156800
- DOI: 10.1016/j.lanepe.2022.100407
Risk of cancer in young and older patients with congenital heart disease and the excess risk of cancer by syndromes, organ transplantation and cardiac surgery: Swedish health registry study (1930-2017)
Erratum in
-
Corrigendum to "Risk of cancer in young and older patients with congenital heart disease and the excess risk of cancer by syndromes, organ transplantation and cardiac surgery: Swedish health registry study (1930-2017)" [The Lancet Regional Health-Europe 18 (2022) 100407].Lancet Reg Health Eur. 2024 Apr 16;40:100911. doi: 10.1016/j.lanepe.2024.100911. eCollection 2024 May. Lancet Reg Health Eur. 2024. PMID: 38655239 Free PMC article.
Abstract
Background: Increasing survival of patients with congenital heart disease (CHD) will result in an increased risk of age-dependent acquired diseases later in life. We aimed to investigate the risk of cancer in young and older patients with CHD and to evaluate the excess risk of cancer by syndromes, organ transplantation and cardiac surgery.
Methods: Patients with CHD born between 1930 and 2017 were identified using Swedish Health Registers. Each patient with CHD (n = 89,542) was matched by sex and birth year with ten controls without CHD (n = 890,472) from the Swedish Total Population Register.
Findings: 4012 patients with CHD (4·5%) and 35,218 controls (4·0%) developed cancer. The median follow-up time was 58·8 (IQR 42·4-69·0) years. The overall cancer risk was 1·23 times higher (95% confidence interval (CI) 1·19-1·27) in patients with CHD compared with matched controls, and remained significant when patients with syndromes and organ transplant recipients were excluded. The risk of cancer was higher in all CHD age groups, and in patients that underwent cardiac surgery during the first year after birth (Hazard Ratio 1·83; 95% CI 1·32-2·54). The highest risk was found in children (0-17 years), HR 3·21 (95% CI 2·90-3·56).
Interpretation: The cancer risk in patients with CHD was 23% higher than in matched controls without CHD. The highest risk was found in children and in the latest birth cohort (1990-2017).
Funding: Funding by the Swedish state (Grant Number: 236611), the Swedish Research Council (Grant Number: 2019-00193), the Swedish Childhood Cancer Fund (Grant Number: SP2017-0012) and the Swedish Heart-Lung Foundation (Grant Number: 20190724).
Keywords: Cancer; Congenital heart defect; Congenital heart disease; Genetics; Risk factor; Thymectomy; Transplantation.
© 2022 The Author(s).
Conflict of interest statement
None reported.
Figures
Similar articles
-
Outcomes after cancer diagnosis in children and adult patients with congenital heart disease in Sweden: a registry-based cohort study.BMJ Open. 2024 Apr 17;14(4):e083237. doi: 10.1136/bmjopen-2023-083237. BMJ Open. 2024. PMID: 38631823 Free PMC article.
-
Risk of Cancer Among Children and Young Adults With Congenital Heart Disease Compared With Healthy Controls.JAMA Netw Open. 2019 Jul 3;2(7):e196762. doi: 10.1001/jamanetworkopen.2019.6762. JAMA Netw Open. 2019. PMID: 31276179
-
Heart failure in patients with congenital heart disease after a cancer diagnosis.ESC Heart Fail. 2024 Oct;11(5):3388-3394. doi: 10.1002/ehf2.14945. Epub 2024 Jul 6. ESC Heart Fail. 2024. PMID: 38970349 Free PMC article.
-
Chronic kidney disease in patients with congenital heart disease: a nationwide, register-based cohort study.Eur Heart J Open. 2022 Sep 2;2(5):oeac055. doi: 10.1093/ehjopen/oeac055. eCollection 2022 Sep. Eur Heart J Open. 2022. PMID: 36213331 Free PMC article.
-
Born to Age: When Adult Congenital Heart Disease Converges With Geroscience.JACC Adv. 2022 Mar 18;1(1):100012. doi: 10.1016/j.jacadv.2022.100012. eCollection 2022 Mar. JACC Adv. 2022. PMID: 38939088 Free PMC article. Review.
Cited by
-
Cumulative Radiation Exposure and Lifetime Cancer Risk in Patients With Tetralogy of Fallot Requiring Early Intervention.JACC Adv. 2024 Sep 6;3(10):101239. doi: 10.1016/j.jacadv.2024.101239. eCollection 2024 Oct. JACC Adv. 2024. PMID: 39290814 Free PMC article.
-
Risk of malignancy in adult patients with congenital heart disease: a clinical practice review.Cardiovasc Diagn Ther. 2025 Feb 28;15(1):195-206. doi: 10.21037/cdt-24-388. Epub 2025 Feb 25. Cardiovasc Diagn Ther. 2025. PMID: 40115083 Free PMC article. Review.
-
Cancer risk subsequent to cardiovascular disease: a prospective population-based study and meta-analysis.BMC Med. 2025 Mar 31;23(1):192. doi: 10.1186/s12916-025-04013-1. BMC Med. 2025. PMID: 40165228 Free PMC article.
-
Effects of antibiotics, hospitalisation and surgical complications on self-reported immunological vulnerability following paediatric open-heart surgery and thymectomy: a single-centre retrospective cohort study.BMJ Paediatr Open. 2024 Jun 3;8(1):e002651. doi: 10.1136/bmjpo-2024-002651. BMJ Paediatr Open. 2024. PMID: 38830724 Free PMC article.
-
Cancer mortality in children surviving congenital heart interventions: A study from the Pediatric Cardiac Care Consortium.Pediatr Blood Cancer. 2024 Dec;71(12):e31271. doi: 10.1002/pbc.31271. Epub 2024 Aug 13. Pediatr Blood Cancer. 2024. PMID: 39138600
References
-
- van der Linde D., Konings E.E., Slager M.A., et al. Birth prevalence of congenital heart disease worldwide: a systematic review and meta-analysis. J Am Coll Cardiol. 2011;58:2241–2247. - PubMed
-
- Hoffman J.I., Kaplan S. The incidence of congenital heart disease. J Am Coll Cardiol. 2002;39:1890–1900. - PubMed
-
- Mandalenakis Z., Rosengren A., Lappas G., et al. Atrial fibrillation burden in young patients with congenital heart disease. Circulation. 2018;137:928–937. - PubMed
LinkOut - more resources
Full Text Sources